Addex Therapeutics (ADXN)
NASDAQ:ADXN

Addex Therapeutics (ADXN) Stock Price & Analysis

41 Followers

ADXN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.55 - $4.33
Previous Close$0.64
Volume98.62K
Average Volume (3M)541.68K
Market Cap
SFr.13.15M
Enterprise Value$6.85M
Total Cash (Recent Filing)SFr.6.96M
Total Debt (Recent Filing)SFr.373.13K
Price to Earnings (P/E)-0.3
Beta1.07
Aug 07, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.37
Shares Outstanding77,134,020
10 Day Avg. Volume103,769
30 Day Avg. Volume541,679
Standard Deviation0.29
R-Squared0.13
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)34.86
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ADXN FAQ

What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was $0.55 and its highest was $4.33 in the past 12 months.
    What is Addex Therapeutics’s market cap?
    Currently, no data Available
    When is Addex Therapeutics’s upcoming earnings report date?
    Addex Therapeutics’s upcoming earnings report date is Aug 07, 2023 which is in 68 days.
      How were Addex Therapeutics’s earnings last quarter?
      Addex Therapeutics released its earnings results on May 11, 2023. The company reported -$0.268 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.268.
        Is Addex Therapeutics overvalued?
        According to Wall Street analysts Addex Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Addex Therapeutics pay dividends?
          Addex Therapeutics does not currently pay dividends.
          What is Addex Therapeutics’s EPS estimate?
          Addex Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Addex Therapeutics have?
          Addex Therapeutics has 19,224,718 shares outstanding.
            What happened to Addex Therapeutics’s price movement after its last earnings report?
            Addex Therapeutics reported an EPS of -$0.268 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.319%.
              Which hedge fund is a major shareholder of Addex Therapeutics?
              Among the largest hedge funds holding Addex Therapeutics’s share is New Leaf Venture Partners, L.L.C.. It holds Addex Therapeutics’s shares valued at N/A.

                ---

                Addex Therapeutics Stock Smart Score

                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -82.55%
                12-Months-Change

                Fundamentals

                Return on Equity
                -195.57%
                Trailing 12-Months
                Asset Growth
                -58.47%
                Trailing 12-Months
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Addex Therapeutics

                Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.

                ---

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                ObsEva
                Mymetics
                Crispr Therapeutics AG
                ADC Therapeutics
                AC Immune SA

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis